HNF4A and acute myeloid leukemia: While all GSK-3 inhibitors and TCF/LEF inhibitors showed the same activity for each member of Wnt family, IWP-2 failed to reproduce the capability of Niclosamide of reducing AML cell viability and sensitizing them to drugs.